Diseases of the Esophagus

Papers
(The H4-Index of Diseases of the Esophagus is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
147. CHARACTERISTICS AND PREDICTORS OF EARLY POSTOPERATIVE RECURRENCE OF ESOPHAGEAL CANCER37
021. THE TOTALLY MECHANICAL COLLARD TECHNIQUE FOR CERVICAL ESOPHAGOGASTRIC ANASTOMOSIS REDUCES ANASTOMOTIC STRICTURE COMPARED WITH TRIANGULAR ANASTOMOSIS: A PROPENSITY SCORE-MATCHED STUDY30
159. AUDIT OF POSTOPERATIVE COMPLICATIONS ACCORDING TO PATHOLOGICAL RESPONSE AFTER TRIMODALITY THERAPY IN OESOPHAGEAL CANCER29
118. USEFULNESS OF PERIOPERATIVE NUTRITIONAL THERAPY WITH THE GLUTAMINE/ARGININE/CALCIUM β-HYDROXY-β-METHYLBUTYRATE PRODUCT IN ESOPHAGEAL CANCER SURGERY27
180. PROGNOSTIC INFLUENCE OF POSTOPERATIVE CRP LEVELS AFTER THORACOSCOPIC ESOPHAGECTOMY IN PATIENTS WITH ESCC25
047. ASSOCIATION OF DIETARY FACTORS AND VOLATILE ORGANIC COMPOUNDS IN STOOL SAMPLES IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE21
237. IMPACT OF LYMPH NODE DISSECTION ON PROGNOSIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENTS UNDERGOING NEOADJUVANT CHEMOIMMUNOTHERAPY FOLLOWED BY RADICAL SURGERY21
167. A CASE REPORT: PERFORATION OF THE ESOPHAGUS CAUSED BY CHOPSTICKS21
156. COMPARISON OF SHORT-TERM POSTOPERATIVE OUTCOMES BETWEEN HAND-ASSISTED LAPAROSCOPIC SURGERY AND LAPAROSCOPIC SURGERY FOR ABDOMINAL APPROACHES IN ESOPHAGEAL CANCER SURGERY20
033. PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED ESOPHAGECTOMY: A 15-YEAR COMPARATIVE ANALYSIS OF 1401 CASES WITH OPEN AND VATS20
297. COMPARING SURVIVAL AND COMPLICATION RATES IN CERVICAL VS. INTRATHORACIC ANASTOMOSIS FOR ELDERLY ESOPHAGEAL CANCER PATIENTS19
107. CAMRELIZUMAB AND LOW-DOSE RADIOTHERAPY WITH CONCURRENT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (NICE-RT STUDY): PRELIMINARY RESULTS19
287. CAMRELIZUMAB, PACLITAXEL AND NEDAPLATIN AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESPRIT): A PHASE II, SINGLE-ARM STUDY18
092. COPING MECHANISMS FOR FINANCIAL TOXICITY AND ITS ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE IN ESOPHAGEAL CANCER SURVIVORS17
The broad impact of functional lumen imaging probe panometry in addition to high-resolution manometry in an esophageal clinical practice15
Can FLIP guide therapy in idiopathic esophagogastric junction outflow obstruction?15
0.2450008392334